Collaboration for implementation of decentralisation policy of multi drug-resistant tuberculosis services in Zambia.


Journal

Health research policy and systems
ISSN: 1478-4505
Titre abrégé: Health Res Policy Syst
Pays: England
ID NLM: 101170481

Informations de publication

Date de publication:
19 Aug 2024
Historique:
received: 08 02 2024
accepted: 20 07 2024
medline: 20 8 2024
pubmed: 20 8 2024
entrez: 19 8 2024
Statut: epublish

Résumé

Multi-drug-resistant tuberculosis (MDR-TB) infections are a public health concern. Since 2017, the Ministry of Health (MoH) in Zambia, in collaboration with its partners, has been implementing decentralised MDR-TB services to address the limited community access to treatment. This study sought to explore the role of collaboration in the implementation of decentralised multi drug-resistant tuberculosis services in Zambia. A qualitative case study design was conducted in selected provinces in Zambia using in-depth and key informant interviews as data collection methods. We conducted a total of 112 interviews involving 18 healthcare workers, 17 community health workers, 32 patients and 21 caregivers in healthcare facilities located in 10 selected districts. Additionally, 24 key informant interviews were conducted with healthcare workers managers at facility, district, provincial, and national-levels. Thematic analysis was employed guided by the Integrative Framework for Collaborative Governance. The principled engagement was shaped by the global health agenda/summit meeting influence on the decentralisation of TB, engagement of stakeholders to initiate decentralisation, a supportive policy environment for the decentralisation process and guidelines and quarterly clinical expert committee meetings. The factors that influenced the shared motivation for the introduction of MDR-TB decentralisation included actors having a common understanding, limited access to health facilities and emergency transport services, a shared understanding of challenges in providing optimal patient monitoring and review and their appreciation of the value of evidence-based decision-making in the implementation of MDR- TB decentralisation. The capacity for joint action strategies included MoH initiating strategic partnerships in enhancing MDR-TB decentralisation, the role of leadership in organising training of healthcare workers and of multidisciplinary teams, inadequate coordination, supervision and monitoring of laboratory services and joint action in health infrastructural rehabilitation. Principled engagement facilitated the involvement of various stakeholders, the dissemination of relevant policies and guidelines and regular quarterly meetings of clinical expert committees to ensure ongoing support and guidance. A shared motivation among actors was underpinned by a common understanding of the barriers faced while implementing decentralisation efforts. The capacity for joint action was demonstrated through several key strategies, however, challenges such as inadequate coordination, supervision and monitoring of laboratory services, as well as the need for collaborative efforts in health infrastructural rehabilitation were observed. Overall, collaboration has facilitated the creation of a more responsive and comprehensive TB care system, addressing the critical needs of patients and improving health outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Multi-drug-resistant tuberculosis (MDR-TB) infections are a public health concern. Since 2017, the Ministry of Health (MoH) in Zambia, in collaboration with its partners, has been implementing decentralised MDR-TB services to address the limited community access to treatment. This study sought to explore the role of collaboration in the implementation of decentralised multi drug-resistant tuberculosis services in Zambia.
METHODS METHODS
A qualitative case study design was conducted in selected provinces in Zambia using in-depth and key informant interviews as data collection methods. We conducted a total of 112 interviews involving 18 healthcare workers, 17 community health workers, 32 patients and 21 caregivers in healthcare facilities located in 10 selected districts. Additionally, 24 key informant interviews were conducted with healthcare workers managers at facility, district, provincial, and national-levels. Thematic analysis was employed guided by the Integrative Framework for Collaborative Governance.
FINDINGS RESULTS
The principled engagement was shaped by the global health agenda/summit meeting influence on the decentralisation of TB, engagement of stakeholders to initiate decentralisation, a supportive policy environment for the decentralisation process and guidelines and quarterly clinical expert committee meetings. The factors that influenced the shared motivation for the introduction of MDR-TB decentralisation included actors having a common understanding, limited access to health facilities and emergency transport services, a shared understanding of challenges in providing optimal patient monitoring and review and their appreciation of the value of evidence-based decision-making in the implementation of MDR- TB decentralisation. The capacity for joint action strategies included MoH initiating strategic partnerships in enhancing MDR-TB decentralisation, the role of leadership in organising training of healthcare workers and of multidisciplinary teams, inadequate coordination, supervision and monitoring of laboratory services and joint action in health infrastructural rehabilitation.
CONCLUSIONS CONCLUSIONS
Principled engagement facilitated the involvement of various stakeholders, the dissemination of relevant policies and guidelines and regular quarterly meetings of clinical expert committees to ensure ongoing support and guidance. A shared motivation among actors was underpinned by a common understanding of the barriers faced while implementing decentralisation efforts. The capacity for joint action was demonstrated through several key strategies, however, challenges such as inadequate coordination, supervision and monitoring of laboratory services, as well as the need for collaborative efforts in health infrastructural rehabilitation were observed. Overall, collaboration has facilitated the creation of a more responsive and comprehensive TB care system, addressing the critical needs of patients and improving health outcomes.

Identifiants

pubmed: 39160603
doi: 10.1186/s12961-024-01194-8
pii: 10.1186/s12961-024-01194-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112

Informations de copyright

© 2024. The Author(s).

Références

Bhargava A, Bhargava M. Tuberculosis deaths are predictable and preventable: comprehensive assessment and clinical care is the key. J Clin Tuberc Mycobact Dis. 2020;19:100155.
Salari N, et al. Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis. Infect Dis Poverty. 2023;12(1):1–12.
doi: 10.1186/s40249-023-01107-x
McGrath M, et al. Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemother. 2014;69(2):292–302.
doi: 10.1093/jac/dkt364 pubmed: 24072169
Mazurek GH, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWr Recomm Rep. 2005;54(RR-15):49–55.
pubmed: 16357824
de Dieu Longo J, et al. Risk factors for multidrug-resistant tuberculosis in the Central African Republic: a case-control study. J Infect Public Health. 2023. https://doi.org/10.1016/j.jiph.2023.06.007 .
doi: 10.1016/j.jiph.2023.06.007 pubmed: 37437428
Misombo-Kalabela A, et al. Risk factors for multidrug-resistant tuberculosis in the city of Kinshasa in the Democratic Republic of Congo. Pan Afr Med J. 2016;23:157. https://doi.org/10.11604/pamj.2016.23.157.6137 .
doi: 10.11604/pamj.2016.23.157.6137 pubmed: 27516818 pmcid: 4967428
Kashongwe IM, et al. Outcomes and adverse events of pre-and extensively drug-resistant tuberculosis patients in Kinshasa, Democratique Republic of the Congo: a retrospective cohort study. PLoS ONE. 2020;15(8): e0236264.
doi: 10.1371/journal.pone.0236264 pubmed: 32750060 pmcid: 7402497
Das M, et al. Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: a qualitative study. PLoS ONE. 2021;16(3): e0248408.
doi: 10.1371/journal.pone.0248408 pubmed: 33690715 pmcid: 7946226
Hales R, Birdthistle N. The sustainable development goal–SDG# 3 good health and well-being. In: Birdthistle N, Hales R, editors. Attaining the 2030 sustainable development goal of good health and well-being. Bingley: Emerald Publishing Limited; 2023. p. 1–12.
Uplekar M, et al. WHO’s new end TB strategy. The Lancet. 2015;385(9979):1799–801.
doi: 10.1016/S0140-6736(15)60570-0
Daru P, et al. Decentralised, community-based treatment for drug-resistant tuberculosis: Bangladesh program experience. Glob Health Sci Pract. 2018;6(3):594–602.
doi: 10.9745/GHSP-D-17-00345 pubmed: 30287534 pmcid: 6172109
Paul S, et al. Knowledge and attitude of key community members towards tuberculosis: mixed method study from BRAC TB control areas in Bangladesh. BMC Public Health. 2015;15(1):1–8.
doi: 10.1186/s12889-015-1390-5
Ministry of Health. National strategic plan for tuberculosis prevention, care and control, 2017–2021. 2017.
Zafar Ullah A, et al. Government–NGO collaboration: the case of tuberculosis control in Bangladesh. Health Policy Plan. 2006;21(2):143–55.
doi: 10.1093/heapol/czj014 pubmed: 16434423
Ogbuabor DC, Onwujekwe OE. Governance of tuberculosis control programme in Nigeria. Infect Dis Poverty. 2019;8:1–11.
doi: 10.1186/s40249-019-0556-2
Kapata N, et al. Scale-up of TB and HIV programme collaborative activities in Zambia—A 10-year review. Trop Med Int Health. 2012;17(6):760–6.
doi: 10.1111/j.1365-3156.2012.02981.x pubmed: 22487607
Emerson K, Nabatchi T, Balogh S. An integrative framework for collaborative governance. J Public Adm Res Theory. 2011;22(1):1–29.
doi: 10.1093/jopart/mur011
Creswell JW, et al. Qualitative research designs: selection and implementation. Couns Psychol. 2007;35(2):236–64.
doi: 10.1177/0011000006287390
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
doi: 10.1191/1478088706qp063oa
Khan U, et al. Re-evaluating the merits of decentralisation as a core strategy for effective delivery of drug-resistant tuberculosis care in Pakistan. Health Policy Plan. 2022;37(8):979–89.
doi: 10.1093/heapol/czac038 pubmed: 35527232
Shelby PW, Lia MP, Israel A. Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016. J Healthc Leadersh. 2017;9:47–57.
doi: 10.2147/JHL.S130207 pubmed: 29355239 pmcid: 5774453
Gilson L. Everyday politics and the leadership of health policy implementation. Health Syst Reform. 2016;2(3):187–93.
doi: 10.1080/23288604.2016.1217367 pubmed: 31514600
Chavula MP, et al. Unlocking policy synergies, challenges and contradictions influencing implementation of the comprehensive sexuality education framework in Zambia: a policy analysis. Health Res Policy and Syst. 2023;21(1):97.
doi: 10.1186/s12961-023-01037-y
Zulu JM, et al. Exploring politics and contestation in the policy process: the case of Zambia’s contested community health strategy. Int J Health Policy Manag. 2022;11(1):24.
pubmed: 34814675
Hamal M, et al. How does social accountability contribute to better maternal health outcomes? A qualitative study on perceived changes with government and civil society actors in Gujarat, India. BMC Health Serv Res. 2018;18(1):653.
doi: 10.1186/s12913-018-3453-7 pubmed: 30134881 pmcid: 6106761
Tetui M, et al. Strengthening research and practice in community health systems: a research agenda and manifesto. Int J Health Policy Manag. 2022;11(1):17.
pubmed: 34380193
Schneider H, et al. The multiple lenses on the Community Health System: implications for policy, practice and research. Int J Health Policy Manag. 2022;11(1):9.
pubmed: 34273937
Zulu JM, et al. Community engagement for the Voluntary Medical Male Circumcision (VMMC) program: an analysis of key stakeholder roles to promote a sustainable program in Zambia. Gates Open Res. 2022;6:50.
doi: 10.12688/gatesopenres.13587.1 pubmed: 37069966
Zulu JM, et al. Barriers and facilitators for integration of guidelines on operating health shops: a case of family planning services. J Pharm Policy Pract. 2021;14(1):1–11.
Chavula MP, et al. Factors shaping responsiveness towards sexual gender-based violence during the COVID-19 Pandemic in Africa: a systematic review. Cogent Public Health. 2023;10(1):2234600.
doi: 10.1080/27707571.2023.2234600
Kielmann K, et al. ‘We had to manage what we had on hand, in whatever way we could’: adaptive responses in policy for decentralised drug-resistant tuberculosis care in South Africa. Health Policy Plan. 2021;36(3):249–59.
doi: 10.1093/heapol/czaa147 pubmed: 33582787 pmcid: 8059133
World Health Organisation. Health policy and system support to optimize community health worker programmes for HIV, TB and malaria services: an evidence guide. 2020.

Auteurs

Malizgani Paul Chavula (MP)

Department of Community and Family Medicine, School of Public Health, University of Zambia, Lusaka, Zambia. paul.malizgani@umu.se.
Department of Epidemiology and Global Health, Umeå University, 901 87, Umeå, Sweden. paul.malizgani@umu.se.

Tulani Francis L Matenga (TFL)

Department of Health Promotion and Education, School of Public Health, University of Zambia, Lusaka, Zambia.

Patricia Maritim (P)

Department of Health Policy and Management, School of Public Health, University of Zambia, Lusaka, Zambia.
Yakini Health Research Institute, Lusaka, Zambia.

Margarate N Munakampe (MN)

Department of Health Policy and Management, School of Public Health, University of Zambia, Lusaka, Zambia.
Yakini Health Research Institute, Lusaka, Zambia.

Batuli Habib (B)

Department of Health Promotion and Education, School of Public Health, University of Zambia, Lusaka, Zambia.

Namakando Liusha (N)

Ministry of Health, Kitwe Teaching Hospital, Off Kumboka Drive, P.O. Box 20969, Kitwe, Zambia.

Jeremiah Banda (J)

Department of Epidemiology and Biostatistics, School of Public Health, University of Zambia, Lusaka, Zambia.

Ntazana N Sinyangwe (NN)

Department of Environmental Health, School of Public Health, University of Zambia, Lusaka, Zambia.

Hikabasa Halwiindi (H)

Department of Community and Family Medicine, School of Public Health, University of Zambia, Lusaka, Zambia.

Chris Mweemba (C)

Department of Health Policy and Management, School of Public Health, University of Zambia, Lusaka, Zambia.

Angel Mubanga (A)

Ministry of Health, Ndeke House, Haile Selassie Avenue, P.O. box 30205, Lusaka, Zambia.

Patrick Kaonga (P)

Department of Epidemiology and Biostatistics, School of Public Health, University of Zambia, Lusaka, Zambia.

Mwimba Chewe (M)

Department of Health Policy and Management, School of Public Health, University of Zambia, Lusaka, Zambia.

Henry Phiri (H)

Ministry of Health, Ndeke House, Haile Selassie Avenue, P.O. box 30205, Lusaka, Zambia.

Joseph Mumba Zulu (JM)

Department of Health Promotion and Education, School of Public Health, University of Zambia, Lusaka, Zambia.
Department of Health Policy and Management, School of Public Health, University of Zambia, Lusaka, Zambia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH